AAAAAA
Results:
1-13
|
Results: 13
Authors:
Takagi, H
Nagamine, T
Abe, T
Takayama, H
Sato, K
Otsuka, T
Kakizaki, S
Hashimoto, Y
Matsumoto, T
Kojima, A
Takezawa, J
Suzuki, K
Sato, S
Mori, M
Citation: H. Takagi et al., Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C, J VIRAL HEP, 8(5), 2001, pp. 367-371
Authors:
Kakizaki, S
Takagi, H
Fukusato, T
Toyoda, M
Horiguchi, N
Sato, K
Takayama, H
Nagamine, T
Mori, M
Citation: S. Kakizaki et al., Effect of alpha-tocopherol on hepatocarcinogenesis in transforming growth factor-alpha (TGF-alpha) transgenic mice treated with diethylnitrosamine, INT J VIT N, 71(5), 2001, pp. 261-267
Authors:
Sugatani, J
Kojima, H
Ueda, A
Kakizaki, S
Yoshinari, K
Gong, QH
Owens, IS
Negishi, M
Sueyoshi, T
Citation: J. Sugatani et al., The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR, HEPATOLOGY, 33(5), 2001, pp. 1232-1238
Authors:
Kawamoto, T
Kakizaki, S
Yoshinari, K
Negishi, M
Citation: T. Kawamoto et al., Estrogen activation of the nuclear orphan receptor CAR (Constitutive active receptor) in induction of the mouse Cyp2b10 gene, MOL ENDOCR, 14(11), 2000, pp. 1897-1905
Authors:
Nagamine, T
Takagi, H
Takayama, H
Kojima, A
Kakizaki, S
Mori, M
Nakajima, K
Citation: T. Nagamine et al., Preliminary study of combination therapy with interferon-alpha and zinc inchronic hepatitis C patients with genotype 1b, BIOL TR EL, 75(1-3), 2000, pp. 53-63
Authors:
Kakizaki, S
Takagi, H
Ichikawa, T
Abe, T
Yamada, T
Suzuki, K
Kojima, A
Takayama, H
Takezawa, J
Nagamine, T
Mori, M
Citation: S. Kakizaki et al., Histological change after interferon therapy in chronic hepatitis C in view of iron deposition in the liver, BIOL TR EL, 73(2), 2000, pp. 151-162
Authors:
Kakizaki, S
Takagi, H
Murakami, M
Takayama, H
Sato, K
Mori, M
Citation: S. Kakizaki et al., HLA-A2 subtype in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C, LIVER, 20(5), 2000, pp. 423-424
Authors:
Toyoda, M
Kakizaki, S
Horiguchi, N
Sato, K
Takayama, H
Takagi, H
Nagamine, T
Mori, M
Citation: M. Toyoda et al., Role of serum soluble Fas/soluble Fas ligand and TNF-alpha on response to interferon-alpha therapy in chronic hepatitis C, LIVER, 20(4), 2000, pp. 305-311
Authors:
Kakizaki, S
Takagi, H
Horiguchi, N
Toyoda, M
Takayama, H
Nagamine, T
Mori, M
Kato, N
Citation: S. Kakizaki et al., Iron enhances hepatitis C virus replication in cultured human hepatocytes, LIVER, 20(2), 2000, pp. 125-128
Authors:
Kakizaki, S
Takagi, H
Yamada, T
Ichikawa, T
Abe, T
Sohara, N
Kosone, T
Kaneko, M
Takezawa, J
Takayama, H
Nagamine, T
Mori, M
Citation: S. Kakizaki et al., Evaluation of twice-daily administration of interferon-beta for chronic hepatitis C, J VIRAL HEP, 6(4), 1999, pp. 315-319
Authors:
Takagi, H
Kakizaki, S
Satoh, K
Toyoda, M
Horiguchi, N
Takayama, H
Kanda, D
Nakajima, H
Ichikawa, T
Kojima, A
Matsuzaki, Y
Shimoda, R
Matsumoto, T
Kaneko, M
Hashimoto, Y
Abe, T
Nagamine, T
Mori, M
Citation: H. Takagi et al., Prevalence of hepatitis G virus in liver disease, CAN J GASTR, 13(10), 1999, pp. 823-826
Authors:
Sato, K
Sato, N
Shimizu, H
Tsutiya, T
Takahashi, H
Kakizaki, S
Takayama, H
Takagi, H
Mori, M
Citation: K. Sato et al., Faropenem enhances superoxide anion production by human neutrophils in vitro, J ANTIMICRO, 44(3), 1999, pp. 337-341
Authors:
Kakizaki, S
Takagi, H
Murakami, E
Takayama, H
Mori, M
Citation: S. Kakizaki et al., HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C, J HEPATOL, 30(5), 1999, pp. 794-800
Risultati:
1-13
|